Year		Degree		Institution
		B.S.		University of Kentucky

Period		Description		Organization
July 2002 - Present		lab manager		Children's Memorial Hospital, Department of Pathology, Chicago, IL
December 1990 - May 2002		lab manager		Chicago Institute for Neurosurgery and Neuroresearch, Chicago, IL and Evanston, IL
May 1990 - December 1990		research technologist II		Northwestern University, Department of Pharmacology and The Cancer Center, Chicago, IL
March 1989 - May 1990		research assistant		Synergen, Department of Pharmaceutics, Boulder, CO
September 1988 - March 1989		senior research analyst		University of Kentucky, Department of Pathology and The Cancer Center, Lexington, KY
October 1986 - September 1988		senior research analyst		University of Kentucky, Department of Microbiology and Immunology and The Cancer Center, Lexington, KY
November 1981 - December 1984		lecturer and translator		Technical University of Wroclaw, Department of Foreign Language, Wroclaw, Poland
1980 - 1981		research analyst		University of Kentucky, Department of Biochemistry and The Sanders-Brown Center on Aging, Lexington, KY
1977 - 1980		principal laboratory technician		University of Kentucky, Department of Chemistry, Lexington, KY

Perlman Lab

C. Cutcliffe, D. Kersey, C-C Huang, Y. Zeng, D. Walterhouse, E.J. Perlman for the Renal Tumor Committee of the Children's Oncology Group (2005). Clear cell sarcoma of the kidney: Up-regulation of neural markers with activation of the sonic hedgehog and Akt pathways. Clinical Cancer Research: Nov 15; 11(22):7986 - 7994.
( Download Adobe Acrobat PDF )

Q. Yang, S. Liu, Y. Tian, C. Hasan, D. Kersey, H. Salwen, A. Chlenski, E. Perlman and S. Cohn (2004). Methylation-associated silencing of the heat shock protein 47 gene in human neuroblastoma. Cancer Research : July 1;64:4531-4538.

R.A. Kroes, A. Jastrow, M.G. McLone, H. Yamamoto, P. Colley, D.S. Kersey, V.W. Yong, E. Mkrdichian, L. Cerullo, J. Leestma and J.R. Moskal (2000). The identification of novel therapeutic targets for the treatment of malignant brain tumors. Cancer Letters: Aug11;156 (2):191-198.

A. Rebbaa, H. Yamamoto, T. Saito, E. Meuillet, P. Kim, D.S. Kersey, E.G. Bremer, N. Taniguchi and J. R. Moskal (1997). Gene transfection-mediated overexpression of beta1,4GlcNAc bisecting oligosaccharides in glioma cell line U373 MG inhibits EGF receptor function. Journal of Biological Chemistry : Apr 4; 272 (14):9275-.

H. Yamamoto, T. Saito, Y. Kaneko, D. Kersey, V.W. Yong, E.G. Bremer, E. Mkrdichian, L. Cerullo, J. Leestma and J.R. Moskal (1997). Alpha2,3-sialyltransferase mRNA and alpha2,3-linked glycoprotein sialylation are increased in malignant gliomas . Brain Research : 755:175-179.

Y. Kaneko, H. Yamamoto, D. Kersey, K. Colley, J. Leestma, and J. Moskal (1996). The expression of Galbeta1,4GlcNAc alpha2,6 sialyltransferase and alpha2,6-linked sialoglycoconjugates in human brain tumors. Acta Neuropathologica : 91:284-292.

A. Rebbaa, J. Hurh, H. Yamamoto, D. Kersey and E. Bremer (1996). Ganglioside GM3 inhibition of EGF receptor mediated signal transduction. Glycobiology 6: 399-406.

H. Yamamoto, Y. Kaneko, D. VanderMeulen, D. Kersey, E. Mkrdichian, L. Cerullo, and J. Moskal (1995). The expression of CMP-NeuAc:Galbeta1,4 GlcNAc alpha2,6 sialyltransferase and glycoproteins bearing alpha2,6-linked sialic acids in human brain tumors. Glycoconjugate Journal : 12:848-856.

M. Turker, K. Duffin, A. Smith, G. Martin, A. Martin, D. DiMartino, and D. Kersey (1991). Multidrug resistance phenotype associated with selection of an aminopterin resistant dog kidney cell line. Pharmacogenetics : 1:149-160.

D. Kersey, C. Hasan, P. Grundy, E. J. Perlman (March, 2003). Genetic expression profiling of clear cell sarcoma of the kidney (CCSK). platform presentation, Society for Pediatric Pathology Annual Meeting. Washington, DC.

Last Updated: Nov 14 2008 6:29AM